-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Deep Medicine Acquisition Corp. (NASDAQ:DMAQ) Sees Significant Increase in Short Interest
Deep Medicine Acquisition Corp. (NASDAQ:DMAQ) Sees Significant Increase in Short Interest
Deep Medicine Acquisition Corp. (NASDAQ:DMAQ – Get Rating) was the target of a significant increase in short interest in the month of September. As of September 15th, there was short interest totalling 2,600 shares, an increase of 8.3% from the August 31st total of 2,400 shares. Approximately 0.0% of the shares of the company are sold short. Based on an average daily volume of 22,500 shares, the short-interest ratio is presently 0.1 days.
Deep Medicine Acquisition Price Performance
Shares of DMAQ opened at $10.08 on Wednesday. Deep Medicine Acquisition has a 1 year low of $9.70 and a 1 year high of $10.99. The company's fifty day moving average is $10.05 and its two-hundred day moving average is $10.01.
Get Deep Medicine Acquisition alerts:Institutional Trading of Deep Medicine Acquisition
Hedge funds and other institutional investors have recently made changes to their positions in the company. Karpus Management Inc. acquired a new stake in Deep Medicine Acquisition in the fourth quarter valued at about $19,801,000. Saba Capital Management L.P. acquired a new stake in shares of Deep Medicine Acquisition in the 4th quarter valued at approximately $8,908,000. Beryl Capital Management LLC purchased a new stake in shares of Deep Medicine Acquisition in the fourth quarter valued at approximately $6,012,000. Oaktree Capital Management LP acquired a new position in Deep Medicine Acquisition during the fourth quarter worth $4,173,000. Finally, Hsbc Holdings PLC purchased a new position in Deep Medicine Acquisition in the first quarter worth $2,976,000. Hedge funds and other institutional investors own 89.62% of the company's stock.
About Deep Medicine Acquisition
(Get Rating)Deep Medicine Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on identifying businesses in the healthcare industry.
See Also
- Get a free copy of the StockNews.com research report on Deep Medicine Acquisition (DMAQ)
- Don't Give Up on These Q3 Losers
- The Anatomy of a Great Pension Plan
- 3 Safe Earnings Plays for a Risk-Off Market
- Tyson Foods Takes a Lickin' and Keeps on Tickin' Lower
- Small-Cap Catalyst Pharma Is Among Market's Best Price Performers
Receive News & Ratings for Deep Medicine Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Deep Medicine Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
Deep Medicine Acquisition Corp. (NASDAQ:DMAQ – Get Rating) was the target of a significant increase in short interest in the month of September. As of September 15th, there was short interest totalling 2,600 shares, an increase of 8.3% from the August 31st total of 2,400 shares. Approximately 0.0% of the shares of the company are sold short. Based on an average daily volume of 22,500 shares, the short-interest ratio is presently 0.1 days.
深度医药收购公司(纳斯达克代码:dmaq-Get Rating)是空头股数9月份大幅增长的目标。截至9月15日,空头股数共有2,600股,比8月31日的2,400股增加了8.3%。该公司约0.0%的股份被卖空。以日均成交量22,500股计算,目前短息比率为0.1天。
Deep Medicine Acquisition Price Performance
深度医疗收购价格表现
Shares of DMAQ opened at $10.08 on Wednesday. Deep Medicine Acquisition has a 1 year low of $9.70 and a 1 year high of $10.99. The company's fifty day moving average is $10.05 and its two-hundred day moving average is $10.01.
周三,DMAQ的股价开盘报10.08美元。深度医药收购的一年低点为9.70美元,一年高位为10.99美元。该公司的50日移动均线切入位在10.05美元,200日移动均线切入位在10.01美元。
Institutional Trading of Deep Medicine Acquisition
深度医药收购的制度性交易
Hedge funds and other institutional investors have recently made changes to their positions in the company. Karpus Management Inc. acquired a new stake in Deep Medicine Acquisition in the fourth quarter valued at about $19,801,000. Saba Capital Management L.P. acquired a new stake in shares of Deep Medicine Acquisition in the 4th quarter valued at approximately $8,908,000. Beryl Capital Management LLC purchased a new stake in shares of Deep Medicine Acquisition in the fourth quarter valued at approximately $6,012,000. Oaktree Capital Management LP acquired a new position in Deep Medicine Acquisition during the fourth quarter worth $4,173,000. Finally, Hsbc Holdings PLC purchased a new position in Deep Medicine Acquisition in the first quarter worth $2,976,000. Hedge funds and other institutional investors own 89.62% of the company's stock.
对冲基金和其他机构投资者最近对他们在该公司的头寸进行了调整。Karpus Management Inc.在第四季度收购了Deep Medicine收购的新股份,价值约为19,801,000美元。萨巴资本管理公司在第四季度收购了深度医药收购公司的新股份,价值约为8,908,000美元。贝丽尔资本管理有限责任公司在第四季度购买了深度医药收购公司的新股份,价值约为601.2万美元。橡树资本管理有限公司在第四季度收购了价值4,173,000美元的Deep Medicine收购的新头寸。最后,汇丰控股在第一季度购买了深医收购的新头寸,价值297.6万美元。对冲基金和其他机构投资者持有该公司89.62%的股票。
About Deep Medicine Acquisition
关于深度医学的收购
Deep Medicine Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on identifying businesses in the healthcare industry.
深度医药收购公司没有重大业务。公司拟与一家或多家企业进行合并、资本换股、资产收购、股票购买、重组或类似的业务合并。它专注于识别医疗保健行业的企业。
See Also
另请参阅
- Get a free copy of the StockNews.com research report on Deep Medicine Acquisition (DMAQ)
- Don't Give Up on These Q3 Losers
- The Anatomy of a Great Pension Plan
- 3 Safe Earnings Plays for a Risk-Off Market
- Tyson Foods Takes a Lickin' and Keeps on Tickin' Lower
- Small-Cap Catalyst Pharma Is Among Market's Best Price Performers
- 免费获取StockNews.com关于深度医学收购的研究报告(DMAQ)
- 不要放弃这些第三季度的失败者
- 一个伟大的养老金计划的剖析
- 避险市场的三大安全收益
- 泰森食品股价下跌,继续走低
- 小盘股Catalyst Pharma是市场上价格表现最好的公司之一
Receive News & Ratings for Deep Medicine Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Deep Medicine Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
接受深度医疗收购日报的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯,接收最新新闻和分析师对深度医药收购和相关公司评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧